ProjectDUPIMORPH
Basic data
Title:
DUPIMORPH
Duration:
21/05/2020 to 30/06/2023
Abstract / short description:
A randomized, placebo-controlled phase IIa clinical trial to evaluate the efficacy and safety of subcutaneous Dupilumab in localized scleroderma
Keywords:
psoriasis therapeutics
Psoriasis Therapeutika
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Köln, Nordrhein-Westfalen, Germany